Nausea and vomiting of pregnancy. Hyperemesis gravidarum, mild or unspecified, starting before the end of the 22nd week of gestation
Conditions
Interventions
Intervention 1: Intervention group:Aromatherapy with essential oil, Once the feeling of nausea 2 drop of solution are placed on the cotton and held 3 cm under nose. Participant were instructed to take
Placebo
Intervention group:Aromatherapy with essential oil, Once the feeling of nausea 2 drop of solution are placed on the cotton and held 3 cm under nose. Participant were instructed to take three slow, dee
Control group:The use of placebo(normal salin): Once the feeling of nausea 2 drop of solution are placed on the cotton and held 3 cm under nose. Patients were instructed to take three slow, deep breat
Sponsors
Research Deputy of Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
16 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 16 to 40 years old; Singleton and normal pregnancy with 6 to16 weeks based on LMP and ultrasound; Being able to compelet questionnaire; Having mild to moderate nausea and vomiting without hyperemesis gravidarum symptoms (based on 3-12 PUQE-24 scores); Not using anti emetic or emetic drugs( herbal or chemical drugs) over the previous 24 hour; Not having psychological problems and unpleasant event over 6 months ago according to pregnant women reporting; Not using tobacco; Not having molar pregnancy; Not having symptoms of Threatened abortion; Not having acute Pyelonephritis; Not having thyroid dysfunction; Not having identified digestive diseases which may cause nausea and vomiting; Having phone; No olfactory disorder. Exclusion criteria: Alergy during aromatherapy; use anti emetic herbal or chemical drugs during study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of nausea and vomiting of pregnancy. Timepoint: Before and during intervention. Method of measurement: 24-hour Pregnancy Unique Quantification of Emesis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: After intervention. Method of measurement: Final questionnaire.;Satisfaction. Timepoint: After intervention. Method of measurement: Final questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarzaneh Safajou
Tabriz University of Medical Sciences
Outcome results
None listed